Alexion Pharmaceuticals (ALXN) News Today → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free ALXN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 2, 2024 | msn.comAlexion’s Voydeya gains FDA approval for extravascular haemolysisMarch 27, 2024 | msn.comUS FDA grants approval for Alexion’s NMOSD treatmentMarch 19, 2024 | businesswire.comJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with AlexionDecember 11, 2023 | stocknews.comCitius Pharmaceuticals (CTXR) Earnings Watch: Pharma Stock Signals for InvestorsDecember 8, 2023 | markets.businessinsider.comLevi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. (ALXN) an Upcoming Claims Deadline in a Class Action SettlementNovember 7, 2023 | investing.comBioMarin Pharma gains on report Elliott has a stakeNovember 6, 2023 | stocknews.comGilead Sciences (GILD) Earnings Forecast and GameplanSeptember 11, 2023 | msn.comAlexion and Verge enter AI-powered drug discovery dealMay 13, 2023 | investing.comAlexion Pharmaceuticals Inc (A1LX34)April 25, 2023 | marketwatch.comWilson Disease Drugs Market Size, Growth Strategies, Gross Margin and Forecast 2029April 10, 2023 | thestreet.comAlexion Reaches New 52-Week High (ALXN)March 4, 2023 | stockhouse.comAlexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023February 9, 2023 | investing.comAstraZeneca goes for growth with new drugs as COVID sales waneJanuary 25, 2023 | seekingalpha.comHealthcare Sector Is Lagging As We Enter 2022 Earnings SeasonJanuary 21, 2023 | thestreet.comSynageva Biopharma (GEVA) Stock More Than Doubles to 52-Week High on Alexion AcquisitionOctober 14, 2022 | finance.yahoo.comAlexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022September 15, 2022 | lse.co.ukUS close: Dow loses almost 1,300 points after hot CPI readingSeptember 1, 2022 | thestreet.comAlexion Stock Hits New 52-Week High (ALXN)July 29, 2022 | uk.investing.comFTSE 100 positive but off best levels, US seen higherMarch 17, 2022 | markets.businessinsider.comAstraZeneca's Unit Alexion To Pay $775 Mln To Chugai On Ultomiris Patent SettlementMarch 1, 2022 | uk.investing.comAstraZeneca inks $760 million deal with Swiss firm Neurimmune for antibody drugJanuary 7, 2022 | msn.comUK pre-market stocks update – Shell, AstraZeneca, Aston Martin, C&CNovember 8, 2021 | finance.yahoo.comWas The Smart Money Right About Piling Into Microchip Technology Incorporated (MCHP)?October 26, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)September 29, 2021 | feeds.benzinga.comAstraZeneca Buys Fortress-Biotech Founded Caelum For $500MSeptember 29, 2021 | financialpost.comAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln dealSeptember 3, 2021 | law360.comAlexion Must Face Claims Of Stalling On Drug After MergerAugust 9, 2021 | finance.yahoo.comWere Hedge Funds Right About Alexion Pharmaceuticals, Inc. (ALXN)?July 24, 2021 | cnbc.comAlexion Pharmaceuticals Inc ALXN-MXJuly 23, 2021 | finance.yahoo.comAstraZeneca Wraps Its Massive Alexion Buyout — Is AZN Stock A Buy Or Sell?July 22, 2021 | finance.yahoo.comAlexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy? Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address You won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW ALXN Media Mentions By Week ALXN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALXN News Sentiment▼0.490.78▲Average Medical News Sentiment ALXN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALXN Articles This Week▼00▲ALXN Articles Average Week Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALNY News RPRX News BMRN News UTHR News CTLT News REGN News VRTX News TAK News GMAB News TEVA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALXN) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWrite this ticker symbol down…StocksToTradeNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alexion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.